Business & Finance
Roivant Expects FDA to Approve First Major Drug
Key Points
Roivant Expects FDA to Approve First Major Drug Roivant Chief Executive Officer Matt Gline expects the FDA to approve the launch of a drug used to fight a debilitating skin disease. He says the drug should be on the market by September. He speaks on "Bloomberg Open Interest."
Aug 6th, 2026
Roivant Expects FDA to Approve First Major Drug
Roivant Chief Executive Officer Matt Gline expects the FDA to approve the launch of a drug used to fight a debilitating skin disease. He says the drug should be on the market by September. He speaks on "Bloomberg Open Interest."